MedPath

Outpatient Percutaneous Coronary Intervention

Terminated
Conditions
Coronary Artery Disease
Interventions
Procedure: Early discharge after percutaneous coronary intervenntion
Registration Number
NCT00419055
Lead Sponsor
University of Pennsylvania
Brief Summary

To determine the safety and feasibility of same day discharge after elective coronary percutaneous intervention in a selected stable patient population. The hypothesis to be tested is that in an appropriately selected stable coronary artery disease population post percutaneous coronary intervention, early discharge is safe and feasible.

Detailed Description

A select stable population of patients undergoing percutaneous coronary intervention are randomized to standard of care in-hospital stay for one night or early discharge to a nearby hotel. During PCI, patients receive bivalirudin as their anti-coagulant and also must be eligible for an angioseal closure device. Patients that stay overnight in the hotel must be accompanied by a family member. They return to the cath lab the next day for groin check and blood work. Satisfaction questionnaires are filled out by all patients.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients with stable coronary artery disease scheduled for elective percutaneous coronary intervention
Exclusion Criteria
  • Patients with acute coronary syndrome, patients with an MI within 30 days, an ejection fraction <30%, those with history of IV Dye allergy, creatinine level>2.2, those with increased risk of infection, those with history of bleeding diathesis or anemia (hemoglobin<11.0 g/dl, platelets <100,000 tho/ul)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1 ControlEarly discharge after percutaneous coronary intervenntionPatients are discharged the day after PCI
2 Study groupEarly discharge after percutaneous coronary intervenntionPatients will be discharged 4-6 hrs after PCI
Primary Outcome Measures
NameTimeMethod
The primary endpoints are patient satisfaction and safety.30 days
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath